TNS Extends Healthcare to Italy

As part of the global strategy to develop its healthcare sector, Taylor Nelson Sofres (TNS) has announced the extension of its global healthcare research offering into Italy.

Fanny Gerli has been appointed as director of the new division. Fanny has 14 years' healthcare research experience in the Italian domestic market having previously worked at InterMatrix and more recently, ISIS.

Fanny will be based in TNS' Milan office and will be supported by Letizia Galli (Associate Director) in Rome. Letizia previously worked in the international healthcare division of TNS based in Epsom and is well positioned to provide a more global strategic perspective for Italian based pharmaceutical clients.

The Italian pharmaceutical market is the fourth largest in Europe (the sixth in the world). The new division means that TNS is represented in all of the five major European pharmaceutical markets, thereby strengthening its position as a leader in healthcare market research in Europe.

The office will offer a range of research solutions to meet clients' information needs throughout the product lifecycle including:

• Market understanding and feasibility
  
• Brand positioning (branding/re-branding)
  
• Communication development (including pre/post-testing)
  
• Brand perception and usage tracking
  
• Pricing
  
• Needs assessment
  
• Continuous services (including patient diary studies, panels and omnibuses).

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

• All news